Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard Post History

by ScienceFirst


V.TLT

Valuation that would bring Accelarated Approval

Look at the market examples. Valuation for an oncology indication like the...

December 15, 2022

V.VPT

RE:RE:LEEDS GENERAL INFIRMARY are trialling our incredible Ventri

Major hospital in UK:   Central to the site is the Jubilee Building,...

December 14, 2022

V.VPT

RE:LEEDS GENERAL INFIRMARY are trialling our incredible Ventri

LEEDS is located in UK, so under NHS.  So I don't think that NICE...

December 14, 2022

V.TLT

RE:The top 10 vaccine companies

Lowest  first-half 2022 sales was 1B$US in sales. Highest first-half...

December 14, 2022

V.TLT

RE:$23M to fund needle-free COVID-19 vaccine trial

This article shows 2 things that should interest us as a guideline...

December 14, 2022

V.TLT

RE:RE:RE:COVID-19 vaccine with TLD1433

No.  But it means our foundation sounds solid with the involvement of a...

December 14, 2022

V.TLT

$23M to fund needle-free COVID-19 vaccine trial

  Vaxxas raises $23M to fund needle-free COVID-19 vaccine trial...

December 14, 2022

V.TLT

The top 10 vaccine companies

    VACCINE PLAYERS The top 10 vaccine...

December 14, 2022

V.TLT

COVID-19 vaccine with TLD1433

NML wouldn't have proposed to involve testing in a second level-4 lab if...

December 13, 2022

V.TLT

COVID-19 vaccine with TLD1433

NML wouldn't have propose to involve testing in a second level-4 lab if...

December 13, 2022

V.TLT

RE:Moderna cancer vaccine

EnriqueSuave ... mRNA technology from BioNTech was initially thought to be...

December 13, 2022

V.TLT

Rutherrin news after FDA NMIBC news

Once granted FDA designation for NMIBC, the market the market will start...

December 13, 2022

V.TLT

RE:RE:RE:RE:Big Pharma Question for The Resident Experts

The "1-2 and done" concept will probably capture the curiosity of...

December 13, 2022

V.TLT

RE:RE:RE:Big Pharma Question for The Resident Experts

Nice point Enriquesuave to mention that, for urologists, our treatment is not...

December 13, 2022

V.TLT

RE:Big Pharma Question for The Resident Experts

Plantrader1 ... Thers no single pattern.  It all depends on a lot of...

December 12, 2022

V.TLT

RE:Sanofi started—and lost—$28B bidding war for Horizon

J&J, Amgen and Sanofi went into a bidding war for Horizon Therapeutics...

December 12, 2022

V.TLT

Sanofi started—and lost—$28B bidding war for Horizon

2nd time in 5-6 years that Sanofi starts a bidding war and lose it. It's...

December 12, 2022

V.TLT

Oncology valuation

Another example of oncology valuation ... Once again above 1B$ in valuation. ...

December 12, 2022

V.TLT

AMGEN buys Horizon Therapeutics for 27B$

Just another example of valuation ... in a bidding between 3 big pharmas ...

December 12, 2022

V.TLT

Optimized group efficacy % @90-days: CR=65%, PR=10%, TR=75%

Without the first 12 patients, these are the efficacy %s that would be...

December 12, 2022

Featured Company